Evidence map›Paper›PMID 38372552›Full record

ReviewLa Tunisie medicale2023

Alia Fazza, Sakina Chemil, Sawssen Miladi, Hiba Boussaa, Yasmine Makhlouf, Kaouther Ben Abdelghani, Ahmed Laatar

Abstract readReviewEnglish Abstract
PubMed Full text at PMC
In one paragraph

Review in La Tunisie medicale, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alia FazzaRheumatology department, Mongi Slim hospital, La Marsa, Tunisia, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Sakina ChemilRheumatology department, independent consultant, Bordj Bou Arreridj, Algeria.
Sawssen MiladiRheumatology department, Mongi Slim hospital, La Marsa, Tunisia, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Hiba BoussaaRheumatology department, Mongi Slim hospital, La Marsa, Tunisia, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Yasmine MakhloufRheumatology department, Mongi Slim hospital, La Marsa, Tunisia, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Kaouther Ben AbdelghaniRheumatology department, Mongi Slim hospital, La Marsa, Tunisia, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Ahmed LaatarRheumatology department, Mongi Slim hospital, La Marsa, Tunisia, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Juvenile idiopathic arthritis (JIA), as a chronic condition, is associated with significant disease- and treatment-related morbidity, thus impacting children's quality of life. In order to optimize JIA management and to ensure the best possible care and outcome for children with rheumatic diseases, dedicated disease activity and damage assessment tools are essential. In recent years, there has been a concerted and important international effort to develop and validate disease activity and outcome instruments specific to JIA. This update aims to describe the main outcome measures currently used in JIA patients. These outcome measures include composite disease activity score, measures of physical function, measures of health related quality of life, clinical measures of damage and the assessment of Parent and child reported outcomes (PCROs).

Indexed as

Arthritis, JuvenileChildHumansOutcome Assessment, Health CareQuality of LifeSeverity of Illness Index

Identifiers

PMID38372552
PMCPMC11217963

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.